Literature DB >> 24549826

Feasibility of capsule endoscopy for direct imaging of drug delivery systems in the fasted upper-gastrointestinal tract.

Pernille Barbre Pedersen1, Daniel Bar-Shalom, Stefania Baldursdottir, Peter Vilmann, Anette Müllertz.   

Abstract

PURPOSE: To develop a minimally-invasive method for direct visualization of drug delivery systems in the human stomach and to compare the obtained results with an established in vitro model. The method should provide the capsule rupture, dispersion characteristics, and knowledge regarding the surrounding physiological environment in the stomach.
METHODS: A capsule endoscopic method was developed. The disintegration time, dispersion characteristics and the impact of the physiological environment on different lipid based delivery systems in different gelatin capsules in the fasted stomach of nine healthy volunteers were visualized. Biorelevant dissolution studies using a USP II apparatus and a droplet size analysis of the released SNEDDS were performed.
RESULTS: Visualization of the behavior of both hard and soft gelatin capsules formulations was possible. The disintegration and dispersion of EP oil in a soft capsule and SNEDDS in a hard shell capsule were visualized. The in vitro release rates were different from the in vivo release rates of the soft capsule due to volume, fluid composition and motility differences but not for the hard capsule containing SNEDDS.
CONCLUSIONS: A minimally-invasive capsule endoscopic method was developed for direct visualizing of drug delivery systems in the human stomach and maybe later, in the duodenum.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549826     DOI: 10.1007/s11095-014-1306-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

1.  Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.

Authors:  G A Digenis; E P Sandefer; R C Page; W J Doll; T B Gold; N B Darwazeh
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

2.  Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.

Authors:  Maria Vertzoni; Jennifer Dressman; James Butler; John Hempenstall; Christos Reppas
Journal:  Eur J Pharm Biopharm       Date:  2005-08       Impact factor: 5.571

3.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

4.  The effect of cross-linking on the in vivo disintegration of hard gelatin capsules.

Authors:  J Brown; N Madit; E T Cole; I R Wilding; D Cadé
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

5.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

Authors:  D F Evans; G Pye; R Bramley; A G Clark; T J Dyson; J D Hardcastle
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

6.  Upper gastrointestinal (GI) pH in young, healthy men and women.

Authors:  J B Dressman; R R Berardi; L C Dermentzoglou; T L Russell; S P Schmaltz; J L Barnett; K M Jarvenpaa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

7.  A gastroscopic and pharmacological study of the disintegration time and absorption of pivampicillin capsules and tablets.

Authors:  H Hey; P Matzen; J T Andersen; E Didriksen; B Nielsen
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

8.  Monitoring the intragastric distribution of a colloidal drug carrier model by magnetic resonance imaging460.

Authors:  H Faas; W Schwizer; C Feinle; H Lengsfeld; C de Smidt; P Boesiger; M Fried; T Rades
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

9.  Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations.

Authors:  A C Perkins; C G Wilson; M Frier; R M Vincent; P E Blackshaw; R J Dansereau; K D Juhlin; P J Bekker; R C Spiller
Journal:  Int J Pharm       Date:  1999-09-20       Impact factor: 5.875

10.  Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities.

Authors:  Pernille Barbre Pedersen; Peter Vilmann; Daniel Bar-Shalom; Anette Müllertz; Stefania Baldursdottir
Journal:  Eur J Pharm Biopharm       Date:  2013-05-31       Impact factor: 5.571

View more
  4 in total

Review 1.  Software for enhanced video capsule endoscopy: challenges for essential progress.

Authors:  Dimitris K Iakovidis; Anastasios Koulaouzidis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-17       Impact factor: 46.802

Review 2.  In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms.

Authors:  Felix Schneider; Mirko Koziolek; Werner Weitschies
Journal:  Pharmaceutics       Date:  2019-08-16       Impact factor: 6.321

3.  Capsule Design for Blue Light Therapy against Helicobacter pylori.

Authors:  Zhangyong Li; Binbin Ren; Haiyan Tan; Shengrong Liu; Wei Wang; Yu Pang; Jinzhao Lin; Chen Zeng
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

4.  Direct visualization of drug behaviors in the upper GI tract via magnetically controlled capsule endoscopy.

Authors:  Yuan-Chen Wang; Jun Pan; Bin Jiang; Yang-Yang Qian; Xiao-Ou Qiu; Yao-Zong Yuan; Zhao-Shen Li; Zhuan Liao
Journal:  VideoGIE       Date:  2021-05-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.